Literature DB >> 21105016

Magnetic resonance imaging of the placenta identifies placental vascular abnormalities independently of Doppler ultrasound.

A Messerschmidt1, A Baschat, N Linduska, G Kasprian, P C Brugger, A Bauer, M Weber, D Prayer.   

Abstract

OBJECTIVE: To evaluate the relationship between placental vascular pathology detected by prenatal magnetic resonance imaging (MRI) and perinatal outcome.
METHODS: This was a retrospective, hospital-based, cross-sectional study in which all fetal MRI examinations of singleton pregnancies with vascular placental pathology (i.e. infarction with/without hemorrhage, subchorionic thrombi/hemorrhages, intervillous thrombi/hemorrhages, or retroplacental hematoma) in the period 2002-2007 were included. The extent of the pathology was expressed as a percentage of the total placental volume. Abnormalities of umbilical artery Doppler ultrasound examinations within 7 days between MRI and ultrasound examination were noted. Death in utero or postnatally was the primary outcome. Gestational age at MRI and at birth and the occurrence of intrauterine growth restriction (IUGR) were noted. Logistic regression analysis was performed to assess the impact of gestational age at MRI, extent of the vascular lesion and presence of pathological Doppler ultrasound measurements on the prediction of mortality.
RESULTS: Fifty-nine structurally normal singleton pregnancies with placental vascular abnormalities were included in the analysis. Mortality rate was 36%; among the survivors, 87% were born before 37 + 0 gestational weeks and 50% suffered from IUGR. In 55% of the pregnancies pathological umbilical artery Doppler findings were identified, of which 27% were non-survivors. Mortality was predicted by earlier gestational age at fetal MRI for placental pathology (P < 0.05) and increasing extent of the vascular lesion (P < 0.05), but not by the presence of pathological Doppler ultrasound data. Accuracy of the prediction was 82%, sensitivity was 67% and specificity 89%.
CONCLUSION: MRI-detected vascular placental pathologies may help to identify pregnancies at risk for adverse outcome and fetal death independently of umbilical artery Doppler status.
Copyright © 2011 ISUOG. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21105016     DOI: 10.1002/uog.8891

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  6 in total

Review 1.  MRI of the placenta - a short review.

Authors:  Sabine Dekan; Nina Linduska; Gregor Kasprian; Daniela Prayer
Journal:  Wien Med Wochenschr       Date:  2012-05

2.  Prenatal diagnosis of a placental infarction hematoma associated with fetal growth restriction, preeclampsia and fetal death: clinicopathological correlation.

Authors:  Alma Aurioles-Garibay; Edgar Hernandez-Andrade; Roberto Romero; Faisal Qureshi; Hyunyoung Ahn; Suzanne M Jacques; Maynor Garcia; Lami Yeo; Sonia S Hassan
Journal:  Fetal Diagn Ther       Date:  2014-05-17       Impact factor: 2.587

3.  In vivo assessment of placental and brain volumes in growth-restricted fetuses with and without fetal Doppler changes using quantitative 3D MRI.

Authors:  N Andescavage; A duPlessis; M Metzler; D Bulas; G Vezina; M Jacobs; S N Iqbal; A Baschat; C Limperopoulos
Journal:  J Perinatol       Date:  2017-08-24       Impact factor: 2.521

4.  Differences in placental capillary shear stress in fetal growth restriction may affect endothelial cell function and vascular network formation.

Authors:  Win M Tun; Choon Hwai Yap; Shier Nee Saw; Joanna L James; Alys R Clark
Journal:  Sci Rep       Date:  2019-07-08       Impact factor: 4.379

5.  Placental damages in preeclampsia - from ultrasound images to histopathological findings.

Authors:  C G Predoi; C Grigoriu; R Vladescu; A E Mihart
Journal:  J Med Life       Date:  2015

6.  MR Imaging of Fetuses to Evaluate Placental Insufficiency.

Authors:  Yoshimitsu Ohgiya; Hiroshi Nobusawa; Noritaka Seino; Osamu Miyagami; Naomi Yagi; Sasamori Hiroto; Jiro Munechika; Masanori Hirose; Nobuyuki Takeyama; Nobuyuki Ohike; Ryu Matsuoka; Akihiko Sekizawa; Takehiko Gokan
Journal:  Magn Reson Med Sci       Date:  2015-11-25       Impact factor: 2.471

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.